Assessing The Economic Impact Of The Introduction Of Daclatasvir In Combination With Asunaprevir For The Treatment Of Chronic Hepatitis C In China
Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.2275
https://www.valueinhealthjournal.com/article/S1098-3015(17)32609-8/fulltext
Section Title :
Disease-Specific Studies
Section Order :
2096
First Page :
A782
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)32609-8&doi=10.1016/j.jval.2017.08.2275